JK

Jonathan Kolle Portfolio

Invests via SMITHBRIDGE ASSET MANAGEMENT Inc./DE | Managed by Jonathan Kolle
Invests via SMITHBRIDGE ASSET MANAGEMENT Inc./DE
Managed by Jonathan Kolle
Automatically Tracked
Tracking: 0 Updated: 22 hours ago
Jonathan Kolle Profile

With a robust background in finance and entrepreneurial ventures, Jonathan Kolle has established himself as an influential figure in the investment landscape. His experience spans various sectors where he has effectively leveraged market trends to drive business growth. As a founder of multiple successful startups, he demonstrates a keen acumen for identifying emerging opportunities and developing innovative solutions that resonate with consumers. Jonathan's deep understanding of capital markets complements his role as an investor-operator, fostering collaboration between teams while steering companies towards strategic success. His reputation for driving operational excellence makes him a valuable asset within both private enterprises and broader financial contexts.

With a robust background in finance and entrepreneurial ventures, Jonathan Kolle has established himself as an influential figure in the investment landscape. His experience spans various sectors where he has effectively leveraged market trends to drive business growth. As a founder of multiple successful startups, he demonstrates a keen acumen for identifying emerging opportunities and developing innovative solutions that resonate with consumers. Jonathan's deep understanding of capital markets complements his role as an investor-operator, fostering collaboration between teams while steering companies towards strategic success. His reputation for driving operational excellence makes him a valuable asset within both private enterprises and broader financial contexts.

Investment Philosophy & Strategy

With a keen focus on innovation and market dynamics, Jonathan Kolle seeks out transformative opportunities that align with evolving consumer needs. His entrepreneurial journey, underscored by a series of successful startups, equips him with unique insights into driving sustainable growth. A strong advocate for leveraging technology to optimize operational processes, he strategically positions investments to capitalize on competitive advantages in various sectors. By fostering collaborative environments among his teams, he enhances execution efficacy while navigating the complexities of capital deployment in fast-paced markets.

With a keen focus on innovation and market dynamics, Jonathan Kolle seeks out transformative opportunities that align with evolving consumer needs. His entrepreneurial journey, underscored by a series of successful startups, equips him with unique insights into driving sustainable growth. A strong advocate for leveraging technology to optimize operational processes, he strategically positions investments to capitalize on competitive advantages in various sectors. By fostering collaborative environments among his teams, he enhances execution efficacy while navigating the complexities of capital deployment in fast-paced markets.

Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
34.75%
Gain +0.06%
Monthly
0.3%
Yearly
3.61%
Drawdown
15.79%
$375.52M
Equity
Holdings
$375.52M
Investment
$145.21M
$230.32M
Profit +$219,853.34
Realized
-$0
Unrealized
$230.32M
Dividends
$105.9M

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.06%
Profit
$219,853.34
Win %
73%
This Week
Compared To Last Week
Gain
-0.02%
Profit
-$79,574.02
Win %
73%
This Month
Compared to last month
Gain
0.85%
Profit
$3.17M
Win %
73%
This Year
Compared to last year
Gain
5.55%
Profit
$19.74M
Win %
73%
Merck & Co., Inc. logo
MRK Merck & Co., Inc.
+3.8%
+$258,095.67
Abbott Laboratories logo
ABT Abbott Laboratories
+0.35%
+$62,299.87
American International Group Inc. logo
AIG American International Group Inc.
0%
$0
Amgen Inc. logo
AMGN Amgen Inc.
0%
$0
Avery Dennison Corporation logo
AVY Avery Dennison Corporation
0%
$0
Bristol-Myers Squibb Company logo
BMY Bristol-Myers Squibb Company
0%
$0
BP p.l.c. Sponsored ADR logo
BP BP p.l.c. Sponsored ADR
0%
$0
Citigroup Inc. logo
C Citigroup Inc.
0%
$0
Colgate-Palmolive Company logo
CL Colgate-Palmolive Company
0%
$0
Cisco Systems, Inc. logo
CSCO Cisco Systems, Inc.
0%
$0
DuPont de Nemours, Inc. logo
DD DuPont de Nemours, Inc.
0%
$0
General Electric Company logo
GE General Electric Company
0%
$0
The Home Depot, Inc. logo
HD The Home Depot, Inc.
0%
$0
Honeywell International Inc. logo
HON Honeywell International Inc.
0%
$0
International Business Machines Corporation logo
IBM International Business Machines Corporation
0%
$0
Intel Corporation logo
INTC Intel Corporation
0%
$0
The Interpublic Group of Companies, Inc. logo
IPG The Interpublic Group of Companies, Inc.
0%
$0
Illinois Tool Works Inc. logo
ITW Illinois Tool Works Inc.
0%
+$1.16
Johnson & Johnson logo
JNJ Johnson & Johnson
0%
$0
Medtronic plc logo
MDT Medtronic plc
0%
$0
Morgan Stanley logo
MS Morgan Stanley
0%
$0
Microsoft Corp. logo
MSFT Microsoft Corp.
0%
$0
Procter & Gamble Co logo
PG Procter & Gamble Co
0%
$0
Charles Schwab Corporation logo
SCHW Charles Schwab Corporation
0%
$0
Vulcan Materials Company logo
VMC Vulcan Materials Company
0%
$0
Wells Fargo & Company logo
WFC Wells Fargo & Company
0%
$0
WSFS Financial Corporation logo
WSFS WSFS Financial Corporation
0%
$0
Exxon Mobil Corporation logo
XOM Exxon Mobil Corporation
0%
+$0.32
Gap Inc. logo
GAP Gap Inc.
0%
$0
4418
441815107
0%
$0
LXK
LXK
0%
$0
SBC
SBC
0%
$0
0019
001957109
0%
$0
ABS
ABS
0%
$0
SGP
SGP
0%
$0
CTX
CTX
0%
$0
WAG
WAG
0%
$0
LU
LU
0%
$0
ADCT
ADCT
0%
$0
0266
026609107
0%
$0
HPQ
HPQ
0%
$0
1667
166751107
0%
$0
0778
077853109
0%
$0
7414
741477103
0%
$0
Sunworks Inc logo
SUNW Sunworks Inc
-73.21%
-$1.8
Oracle Corporation logo
ORCL Oracle Corporation
-8.83%
-$100,542.2
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
46
Longs Won
24/46 52%
Profit Factor
14.39
Profitability
Shorts Won
0/0 0%
Standard Deviation
$9.11M
Average Win
$10.31M
Best Trade
(Oct 15) $34.57M
Sharpe Ratio
0
Average Loss
-$781,728.9
Worst Trade
(Oct 15) -$8.71M
Z-Score
0.16 (12.9%)
Commissions
$0
Avg. Trade Length
26y 9m 3w 4d
Expectancy
$5.01M
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.9%
Consecutive Losing Trades 480 432 384 336 288 240 192 144 96 48
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit (&#36;) Gain (%) Change
0019
001957109
7,264 $369,000 $369,000 - - -
0.0
0266
026609107
9,000 $353,000 $353,000 - - -
0.0
0778
077853109
6,800 $419,000 $419,000 - - -
0.0
1667
166751107
4,472 $387,000 $387,000 - - -
0.0
4418
441815107
15,300 $570,000 $570,000 - - -
0.0
7414
741477103
90,700 $3.35M $3.35M - - -
0.0
ABS
ABS
33,450 $1.08M $1.08M - - -
0.0
Abbott Laboratories logo
ABT Abbott Laboratories
173,055.19 $2.82M $17.82M - $15M 531.68%
+0.351%
ADCT
ADCT
40,650 $2.95M $2.95M - - -
0.0
American International Group Inc. logo
AIG American International Group Inc.
4,340.85 $5.54M $337,067 - -$5.2M -93.91%
0.0
Amgen Inc. logo
AMGN Amgen Inc.
4,000 $240,000 $1.65M - $1.41M 588.07%
0.0
Avery Dennison Corporation logo
AVY Avery Dennison Corporation
65,550 $4.78M $11.19M - $6.41M 134.26%
0.0
Bristol-Myers Squibb Company logo
BMY Bristol-Myers Squibb Company
8,355.45 $509,999.96 $473,503.35 - -$36,496.61 -7.16%
0.0
BP p.l.c. Sponsored ADR logo
BP BP p.l.c. Sponsored ADR
73,242 $4.34M $3.55M - -$789,565.74 -18.18%
0.0
Citigroup Inc. logo
C Citigroup Inc.
1,331.27 $556,003.7 $165,782.69 - -$390,221.01 -70.18%
0.0
Colgate-Palmolive Company logo
CL Colgate-Palmolive Company
9,200 $299,000 $827,540 - $528,540 176.77%
0.0
Cisco Systems, Inc. logo
CSCO Cisco Systems, Inc.
133,600 $7.16M $15.37M - $8.22M 114.83%
0.0
CTX
CTX
58,950 $1.46M $1.46M - - -
0.0
DuPont de Nemours, Inc. logo
DD DuPont de Nemours, Inc.
32,144.88 $2.56M $4.16M - $1.6M 62.5%
0.0
Gap Inc. logo
GAP Gap Inc.
89,235 $4.11M $2.04M - -$2.07M -50.37%
0.0
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
FAQ
Which stocks have generated the highest profits for Jonathan Kolle?
The largest contributions to the portfolio's profits come from the following stocks: General Electric Company - $12.09M, Exxon Mobil Corporation - $9.86M, Johnson & Johnson - $9.56M, The Home Depot, Inc - $9.14M, and Illinois Tool Works Inc - $7.51M. These positions have been the main drivers of growth and have significantly impacted the investor's overall performance.
What dividends does Jonathan Kolle's portfolio generate?
The portfolio generates substantial dividend income, with a total of $105.9M earned over time. The largest contributors to dividend income include General Electric Company - $12.09M, Exxon Mobil Corporation - $9.86M, Johnson & Johnson - $9.56M, The Home Depot, Inc - $9.14M, and Illinois Tool Works Inc - $7.51M. This indicates that dividends play a meaningful role in the investor's overall strategy.
How stable are Jonathan Kolle's monthly returns?
Jonathan Kolle's monthly returns appear quite volatile. The gap between stronger and weaker months is meaningful, which suggests that the strategy can experience noticeable swings over relatively short periods. For users assessing this profile, that usually means returns may be attractive over time, but the path can be uneven and harder to tolerate during weaker periods.
Can Jonathan Kolle's strategy be considered aggressive or moderate?
Jonathan Kolle's strategy appears moderately aggressive. The portfolio shows a clear focus on growth, with noticeable volatility and risk exposure, although not to an extreme level. This type of strategy may appeal to users seeking higher returns while accepting meaningful fluctuations along the way.
Should beginners follow Jonathan Kolle's strategy?
Jonathan Kolle's strategy is unlikely to be suitable for beginners. The portfolio shows signs of high risk, significant volatility, or structural complexity, which can make it difficult to follow and potentially stressful for less experienced users. This type of approach is generally better suited to more advanced investors.
Account USV